Rivista di formazione e di aggiornamento professionale del pediatra e del medico di base, realizzata in collaborazione con l'Associazione Culturale Pediatri
Gli articoli più visti nel mese di Novembre 2019
1) Problemi non correnti - Settembre 1997
APEC: esantema periflessurale asimmetrico
- M. Cutrone
- The paper describes a new entity, the Asymmetric Periflexural Exanthem of Childhood (APEC), first described in 1962 and recently recognized as a separate clinical entity by many Authors. It is characterized by scarlatiniform or papular rash which develops usually from a periflexural (axillary or inguinal) area to the thoracic area but with a clear monolateral preference. Respiratory or gastrointestinal symptoms may accompany the eruption. Occasionally moderate pruritus and regional lymphoadenopathy are present. The course is self-limited. This entity is believed to be caused by a virus but no single agent has been identified as a causal agent sofar. The Authors observed 4 cases of APEC over a period of four months in 18 to 24-month old children. It is probable that APEC can be diagnosed more often if increased attention is payed by paediatricians.
114 kB2) Problemi correnti - Giugno 2000
Trattare la mononucleosi?
- M. Fontana
- Symptoms are usually mild in young children, but in older children and adolescents systemic and pharingeal complains can be more severe, sometimes with significant airway obstruction. Only supportive care is usually recommended. This paper reports the risults of a recent meta-analysis reviewing the use of acyclovir in IM. This review concludes that acyclovir is effective when administred whithin the first seventytwo hours from the onset of the disease and recommends acyclovir for immunocompromised patients. Pros and cons of steroids treatment is also discussed and the authors conclude that the risks outweigh the benefits.
3) Aggiornamento - Novembre 2019
La vertigine in età pediatrica
- M.V. Abate, A.M. Pusateri, G. Danesi, L. D’Antiga
- Dizziness is a recurrent symptom in children that is often underestimated and incorrectly evaluated. The inability of affected children to explain the characteristics of the experienced symptoms may preclude the diagnosis making, especially in very young children. The etiopathology of vertigo in children differs from the one in adults. The improvement of knowledge about the causes of vertigo in childhood and the introduction of new vestibular tests allow the diagnosis to be made and neuroimaging that are often unnecessary to be reduced. This article describes the main causes of dizziness in children and indicates clinical signs, diagnosis and treatment.
5) Consensus - Novembre 2019
La sindrome nefrosica in età pediatrica
- Consensus della Società Italiana di Nefrologia Pediatrica (SINePe)
- In Italy are not guidelines for the management of idiopathic nephrotic syndrome (NS) in paediatric age. The choice of a treatment with steroids has always been based on the clinical experience of each centre. The present Consensus of the Italian Paediatric Nephrology Association, updated as an overview of the literature in August 2015, aims to provide a multidisciplinary review on the diagnosis and treatment of NS at the onset by proposing a shared therapeutic protocol for both hospital and family paediatricians. The Consensus gives recommendations on the early recognition and treatment of complications (oedema, hypovolemia, infections and thromboembolic events) as well as on the definition of cortico-resistance and indications on the performance of kidney biopsy.
6) La pagina gialla - Novembre 2019
a cura di Alessandro Ventura7) Per una pediatria basata sull'evidenza - Giugno 2000
Varicella e aciclovir
- E. Neri, I. Bruno, C. Salvatore, F. Braida, E. Barbi
- Chicken pox is still a common disease, usually with a favourable course. Complications are rare (2-3/100.000) in immunocompetent patients. The Authors review the published experience regarding treatment with acyclovir and conclude that the advantage is marginall (25% reduction of the duration of symptoms), while there is no reduction in the rate of complications. Acyclovir should be used in immunocompromised patients including primary immune deficiencies, patients treated with steroids or long-term salycilates, patients affected by chronic lung diseases, eczema, diabetes and heart diseases.